BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Braeburn Announces FDA Advisory Committee Recommends Approval of CAM2038 Buprenorphine Depot for the Treatment of Opioid Use Disorder

  Braeburn today announced that the U.S. FDA Psychopharmacologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee jointly voted 17-3 recommending approval of CAM2038, .

  November 1, 2017

   · 

  3 min read
• Pharm Country

  ERT Recognized for Excellence in Patient Centricity

  The award is for TARGET My Hives, a patient community app from ERT that enables access to an online network of resources and health professionals for patients with chronic urticaria (hives).

  November 1, 2017

   · 

  2 min read
• Deals

  Almac Group Announces Acquisition of BioClin Laboratories

  The acquisition will see BioClin’s analytical experts join Almac Sciences’ strong network of almost 600 employees across multiple sites in Europe and North America.

  November 1, 2017

   · 

  3 min read
• BioForest

  Omeros Announces Upcoming Presentation of Clinical OMS721 Data at the American Society of Nephrology Annual Meeting

  The presentation will be made at the American Society of Nephrology Meeting, which is being held October 31 through November 5 in New Orleans.

  November 1, 2017

   · 

  4 min read
• Complix to Present Its Cell Penetrating Alphabod Platform Acting on Important Intracellular Targets at PEGS Europe 2017

  Complix announces that its Chief Scientific Officer, Dr Yvonne McGrath, will be presenting its recent developments on CPABs against intracellular targets at the 9th Annual PEGS Europe Meeting in Lisbon Portugal, November 13-17.

  November 1, 2017

   · 

  1 min read
• Business

  Tocagen to Report Third Quarter 2017 Financial Results on Wednesday, November 8

  Tocagen today announced it will report its third quarter 2017 financial results and business progress on Wednesday, November 8, 2017, after the close of the U.S. financial markets.

  November 1, 2017

   · 

  1 min read
• Drug Development

  Blueprint Medicines Announces Publication of BLU-285 Translational Data

  Reported preclinical data and clinical case studies showed that BLU-285 is a potent and highly selective inhibitor of KIT and PDGFR kinases, which are implicated in multiple diseases including GIST and SM.

  November 1, 2017

   · 

  8 min read
• Business

  DURECT Corporation Announces Third Quarter 2017 Financial Results and Provides Corporate Update

  DURECT Corporation today announced financial results for the three months ended September 30, 2017 and provided a corporate update.

  November 1, 2017

   · 

  20 min read
• Business

  REGENXBIO to Host Conference Call on November 8 to Discuss Third Quarter 2017 Financial Results and Recent Operational Highlights

  The will host a conference call to discuss its financial results for the quarter ended September 30, 2017 and recent operational highlights.

  November 1, 2017

   · 

  1 min read
• Deals

  MediPines Acquires Oxistimulator Technology From Mayo Clinic

  MediPines announced today that it has acquired medical technology designed to reduce respiratory complications in post-surgical patients by preventing oxygen desaturations.

  November 1, 2017

   · 

  2 min read